Airborne fluorescent pseudomonads : What potential for virulence?

International audienc

GREAT — a randomized aneurysm trial. Design of a randomized controlled multicenter study comparing HydroSoft/HydroFrame and bare platinum coils for endovascular aneurysm treatment

International audienceThe effectiveness of a hybrid hydrogel platinum detachable coil (HydroCoil; MicroVention Inc., Tustin, CA) for endovascular aneurysm treatment has been proven in a recently published RCT. Due to technical restrictions (coil stiffness, time restriction for placement), the HydroSoft coil as well as a corresponding 3D framing coil, the HydroFrame coil (MicroVention Inc., Tustin, CA), a class of new softer coils containing less hydrogel and swelling more slowly than the HydroCoil, have been developed and brought to clinical practice. The present study aims to compare the effectiveness of endovascular aneurysm treatment with coil embolization between patients allocated HydroSoft/HydroFrame versus bare platinum coiling. GREAT is a randomized, controlled, multicentre trial in patients bearing cerebral aneurysms to be treated by coil embolization. Eligible patients were randomized to either coil embolization with HydroSoft/HydroFrame coils (>50 % of administered coil length), or bare platinum coils. Inclusion criteria were as follows: age 18-75, ruptured aneurysm (WFNS 1-3) and unruptured aneurysm with a diameter between 4 and 12 mm. Anatomy such that endovascular coil occlusion deemed possible and willingness of the neurointerventionalist to use either HydroSoft/HydroFrame or bare platinum coils. Exclusion criteria were as follows: aneurysms previously treated by coiling or clipping. Primary endpoint is a composite of major aneurysm recurrence on follow-up angiography and poor clinical outcome (modified Rankin scale 3 or higher), both assessed at 18 months post treatment. Risk differences for poor outcomes will be estimated in a modified intention-to-treat analysis stratified by rupture status (DRKS-ID: DRKS00003132)

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Fusarium – cereal interaction in the grain: a dialog with chemical words

International audienc

Molecular mechanisms controlling mycotoxins biosynthesis by the micromycete fungus Fusarium graminearum

Fusarium graminearum est un champignon filamenteux qui parasite les plantes céréalières et le maïs et provoque la fusariose de l épi. Durant l infection, ce champignon produit des mycotoxines de la famille des trichothécènes qui s accumulent dans les grains. Les processus de décontamination existants ne permettent pas d éliminer complètement les trichothécènes. Ainsi, le meilleur moyen pour éviter leur accumulation dans les grains serait de pouvoir limiter leur occurrence au champ en contrôlant leur biosynthèse. Bien que la voie de biosynthèse des trichothécènes et les gènes Tri qui y sont impliqués soient bien décrits, les connaissances de base sur les mécanismes de régulation de ces gènes restent trop restreintes.Dans la première partie de ce travail, l effet du pH sur la régulation des gènes Tri et la production de trichothécène a été étudié. En premier lieu, nous avons démontré que, in vitro, un pH acide joue le rôle d inducteur alors qu un pH neutre ou alcalin bloque l expression des gènes Tri et la production de trichothécène. Ensuite, FgPac1, l homologue du gène pacC/RIM101 codant le facteur de régulation par le pH chez les champignons a été identifié dans le génome de F. graminearum. A l aide de souches recombinantes, nous avons démontré que la forme mature de ce facteur réprime l expression des gènes Tri à pH acide et réduit la virulence du champignon lors de l infection d épis de blé. Enfin, le transcriptome de F. graminearum en réponse au pH et le rôle de Pac1 dans cette réponse a été analysé.Dans la deuxième partie de ce travail, le gène velvet sensible à la lumière, a été identifié chez F. graminearum. Ce gène constitue la composante clef d un complexe qui coordonne la perception de la lumière avec le développement mais aussi avec le métabolisme secondaire chez les champignons. L inactivation de FgVe1 chez F. graminearum nous a permis de démontrer son rôle dans le développement et la production de spores. Elle a montré aussi que ce gène est nécessaire pour permettre l expression des gènes Tri, la production de trichothécène et la pathogénicité in planta.L ensemble de ce travail permet de mieux comprendre la régulation de la production de trichothécène chez F. graminearum et ouvre des perspectives qui permettront sans doute, à long terme, d élaborer des stratégies de lutte contre l accumulation de trichothécène au champ.The filamentous fungus Fusarium graminearum infects cereals plants and corn and causes Fusarium Head Blight . During infection, it produces mycotoxins belonging to trichothecenes family which accumulate in the grains. The available decontamination processes do not fully eliminate the trichothecene. Hence, the best way to avoid their occurrence in the grains is to limit their accumulation in the field by controlling their biosynthesis. Although the Tri genes implicated in the trichothecene biosynthetic pathway are well described, the basic knowledge regarding their regulation is still too limited.In the first part of this work, the effect of the pH on Tri genes regulation and trichothecene production was studied. First, we demonstrated that, in vitro, acidic pH acts as an inducer while a neutral or alkaline pH blocks Tri genes expression and trichothecene production. Then, FgPac1, the homologue of the pacC/RIM101 gene encoding the fungal pH regulatory factor was identified. Using recombinant strains, we demonstrated that the mature form of this factor represses Tri gene expression at acidic pH and reduces virulence during infection of wheat spikes. Finally, we analyzed the transcriptome of F. graminearum in response to pH and investigated the role of Pac1 in this response.In the second part of this work, the light-responsive velvet gene was identified in F. graminearum. This gene is the key component of a complex coordinating light perception with development and secondary metabolism in fungi. The disruption of FgVe1 in F. graminearum demonstrated its role in development and spores production. It also showed that this gene is necessary for Tri gene expression, trichothecene production and pathogenicity in planta.Overall, this work allows a better understanding of trichothecene regulation in F. graminearum and provides novel perspectives to develop new strategies against trichothecene accumulation during cereal growing in the field.BORDEAUX1-Bib.electronique (335229901) / SudocSudocFranceF

Fusarium graminearum : Genome + Epigenome = mycotoxins ?

National audienc

An efficient and easy method of infection of mosquito larvae from virus-contaminated cell cultures

International audienc

The pH regulatory factor Pac1 regulates Tri gene expression and trichothecene production in Fusarium graminearum

International audienceFungi manage the adaptation to extra-cellular pH through the PacC transcription factor, a key component of the pH regulatory system. PacC regulates the production of various secondary metabolites in filamentous fungi. In the important cereal pathogen Fusarium graminearum, the production of trichothecene is induced only under acidic pH conditions. Here, we examined the role of the PacC homologue from F. graminearum, FgPac1, on the regulation of trichothecene production. An FgΔPac1 deletion mutant was constructed in F. graminearum which showed a reduced development under neutral and alkaline pH, increased sensitivity to H2O2 and an earlier Tri gene induction and toxin accumulation at acidic pH. A strain expressing the FgPac1c constitutively active form of Pac1 exhibited a strongly repressed Tri gene expression and reduced toxin accumulation at acidic pH. These results demonstrate that Pac1 negatively regulates Tri gene expression and toxin production in F. graminearum